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TECHNICAL NOTE
Changes in plasma oncotic pressure during isolated
ultrafiltration
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Many dialysis patients have a decrease in blood pressure
during dialytic treatment, and at least 25% of such episodes are
symptomatic [1]. Important factors in these hypotensive epi-
sodes include hypovolemia secondary to filtration of fluid from
the vascular space [2—5], changes in peripheral vascular resist-
ance induced by dialysis [4, 6—10], and hypoosmolarity [11—141.
The latter factor promotes water displacement from the vascu-
lar to the interstitial compartment, aggravating existent hypovo-
lemia.
Experience demonstrates that hemodialysis is accompanied
by hypotension more frequently than it is by isolated ultrafiltra-
tion [3, 4, 15]. Sustained plasma osmolarity and volume or
increased peripheral vascular resistance during ultrafiltration is
thought responsible for the observed blood pressure stability [4,
5]. Presumably, colloid osmotic pressure (COP) and other
Starling forces minimize intravascular volume contraction dur-
ing ultrafiltration [1, 16].
If fluid and nonprotein solutes are removed from the vascular
space, COP should increase as the result of an increase in
protein concentration. Provided the ultrafiltrate removal rate
from the vascular space remains greater than the refilling rate
from the interstitial space, a progressive increase in COP is
expected as a reflection of changes in the intravascular volume
and plasma protein concentration [17]. Because an exponential
relationship exists between COP and protein concentration
[18], the magnitude of change in COP is greater than that for the
plasma protein concentration. This inherent interrelationship of
COP and intravascular volume may permit COP to serve as a
sensitive monitor of vital clinical parameters during dialysis
treatment. Measurement of COP in dialysis patients during
treatment is not reported, however.
The present study, using an original device, directly mea-
sures the dynamic changes in COP among dialysis patients
undergoing ultrafiltration. The changes in COP are evaluated
relative to simultaneous determinations of plasma osmolarity,
plasma protein concentration, hematocrit, arterial pressure,
ultrafiltrate volume, and body weight.
Methods
Four female and 14 male maintenance hemodialysis patients,
29 to 55 years old, receiving clinically indicated sequential
hemofiltration using hollow fiber dialyzers were studied. Blood
samples for determination of COP, plasma protein concentra-
tion, plasma osmolarity, and capillary hematocrit values were
obtained before beginning ultrafiltration and at 0, 15, 30, and 60
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mm of treatment. The ultrafiltrate collected at a constant rate
from each subject accumulated in a graduated flask. Blood
pressure and body weight were monitored throughout the study
using a standard aneroid sphygmomanometer and a constant
weighing electronic bed scale. The mean arterial pressure was
calculated (systolic — diastolic blood pressure — 3 + diastolic
pressure). The concentration of plasma protein was measured
photometrically, and total freezing-point depression determined
plasma osmolarity. Statistical analysis was done by means of
Student's t test and linear and nonlinear regression.
Relationships of COP, MAP, and ultrafiltrate during a con-
stant rate of ultrafiltration were evaluated in three groups of six
patients divided according to the total volume of fluid removed
at 60 mm: group a, 2.4 liters; group b, 2 liters; group c, 1.5 liters
of ultrafiltrate. Measurements were also recorded at 45 mm in
groups a and b.
Plasma osmolarity, protein concentration, hematocrit, and
ultrafiltrate volume were measured serially in group c and
evaluated relative to sequentially measured COP during ultrafil-
tration through 120 mm. A slower rate of ultrafiltration in this
group permitted a longer observation period.
Colloid osmotic pressure was determined by a device con-
taining two chambers separated by a semipermeable membrane
(Fig. 1). The system uses the principle of convective transfer of
solvent and diffusible solutes by the oncotic pressure differ-
ences in the solutions on either side of the membrane. Fluid
movement across the membrane is detected by the pressure
transducer. The validity of this principle has been demonstrated
in previous work by other investigators [19—22].
The two chambers or cells (a and b) of the devices are
constructed of methyl methacrylate. The semipermeable mem-
brane (SM) is a PM-30 from Amicon Corporation, Lexington,
Massachusetts. Neopream '0' rings seal the junctions of M2
component and the transducer (T) as well as semipermeable
membrane and M1 component. Cell a (Ca) is limited laterally by
the M2 cylindrical component. The semipermeable membrane
(SM) serves as this cell cover. The M3 component first mini-
mizes the volume of the reference solution in cell a, increasing
the ratio of membrane area to fluid volume, which augments the
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Fig. 1. Upper panel A top view of the oncometer. Lower panel A
sectional view. Ca is a chamber containing reference solution; Cb,
chamber containing sample; SM, semipermeable membrane; M1, meth-
yl methacrylate component containing Cb; 0, opening bored in M2; M3,
methyl methacrylate component supporting SM and minimizing the
volume of the sample placed on Cb; T, pressure transducer; A,
amplifier; Rc, recorder; S, stopcock valve, and Re, reservoir.
rate at which oncotic equilibrium is achieved. Second, it avoids
membrane displacement, which could adversely affect COP
measurement. Component M1 is attached to M2 by four metallic
screws. Cell b (Cb) is positioned above cell a, accommodating
the sample for COP determination. Cell a communicates to
atmospheric pressure through an opening (0) located in the M2
component. A stopcock via a plastic tube connects the opening
to a calibration reservoir (Re) filled with 0.9% saline. A Statham
P23Db pressure transducer (T) detects any volume-pressure
changes in cell a; the resulting electrical signal is amplified (A)
by a Grass Polygraph, Model 7, Quincy, Massachusetts, and
recorded by a Perkin-Elmer Model 56 recorder (R).
The sequence for measurement of COP includes the follow-
ing: Step I. Reservoir, plastic tubings, opening, and cell a are
filled with 0.9% saline. This serves as a reference solution. Step
2. The semipermeable membrane is placed on the M2 compo-
nent while the stopcock remains closed and the M1 component
is tightly joined to the M2 component with the four screws
across the '0' rings. Step 3. Cell b is filled with 0.9% saline, and
10 mm are allowed to establish hydrostatic and osmotic equilib-
rium. This is confirmed by opening and closing the stopcock,
which at equilibrium, will not alter the transducer's electrical
baseline signal. This signal establishes the system's zero value.
This maneuver, repeatable between measurements, checks the
reproducibility of the zero value. Step 4. The 0.9% saline
column in the reservoir is displaced both 20 cm above and
below original level, with the stopcock in the open position. The
magnitude of the recorded signal, positive or negative, should
be equal. Step 5. The stopcock is closed, and the normosaline
solution is drained from cell b, retaining only enough saline to
wet the semipermeable membrane. Step 6. A 0.4-mI plasma
sample is placed on the semipermeable membrane (cell b); the
COP is recorded after electrical equilibrium is achieved. This is
documented on the polygraph as an asymptotic curve in about 3
mm. Step 7. The zero COP value is reestablished by draining
the serum sample from cell b and replaced with the 0.9% saline.
A reference albumin solution of known oncotic pressure is
measured at intervals to ensure accuracy of the technique.
Results
The method was evaluated for reproducibility (mean SEM)
in 100 determinations of a 5% albumin solution (23.8 0.56 cm
H20). Also, clinical COP control measurements (mean SEM)
were obtained from 50 normal subjects (34.2 3.7 cm H20),
from 65 randomly selected hospital patients (27.2 4.6 cm
H2O), and in 25 uremic patients (26.4 2.9 cm H20).
To verify the reported exponential relationship between COP
and plasma protein concentration using the present method, we
determined COP in solutions containing different concentra-
tions of albumin (Fig. 2).
There is no difference in the absolute baseline mean values
for any of the parameters in three groups of patients. During
ultrafiltration, Fig. 3 shows the parameters expressed as per-
cent changes. The MAP is presented as a positive change to
facilitate comparison with the other parameters. The COP
increases, and the MAP decreases progressively with ultrafil-
tration. These changes are significant for both COP and MAP at
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Fig. 2. Exponential relationship between colloid osmotic pressure(COP) and albumin concentration. Increasing dilutions of albumin were
achieved using normal saline.
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15 (P < 0.002 and <0.05), 30 (P < 0.05 for both), and 60 mm (P
<0.0005 and <0.05), but for COP, they are most pronounced
at 15 mm. From the beginning, the magnitude of the increment
in COP is greater than that of MAP, becoming significantly so at
60 mm (P < 0.01). In addition, an exponential relationship
exists between zCOP and LMAP (y = 10.6 — 0.5X + 0.993X2, P
<0.001).
In Fig. 4, the upper panel displays the three groups of patients
(a, b, and c) according to the amount of fluid ultrafiltrated
through 60 mm. The middle panel shows a progressive incre-
ment in COP in group a which, at 60 mm, is greater than that
observed in groups b and c (P < 0.05). The lower panel
demonstrates a progressive decrease in MAP in groups a and b
(P < 0.002 and <0.01). Differences in MAP at 60 mm are noted
with each group, but the absolute values for MAP at 60 mm are
different only between groups a and c (P < 0.05).If the changes
to 15 mm are ignored, an exponential increase of COP during
ultrafiltration is again noted with groups a and b (P < 0.0005 and
<0.002) but this increase is linear in group c (P < 0.005). An
exponential decrease of MAP is also apparent for all groups (P
<0.005). It is apparent that as more ultrafiltrate is removed, the
slopes of change in COP and MAP become steeper.
Figure 5 shows that COP relates exponentially with ultrafil-
trate volume (P < 0.0001), total protein (P < 0.005), and
hematocrit (P < 0.0005). The magnitude of increment in COP at
120 mm, however, is greater than that for total protein or
hematocrit (P < 0.02 or < 0.05). Ifhematocrit and total protein
are related to ultrafiltrate alone, the relationships are linear (P
<0.001). There were no changes in plasma osmolarity through-
out the 2-hour period of ultrafiltration.
Discussion
The present study demonstrates that ultrafiltration produces
a significant increase of COP. These changes are primarily
related to the volume of fluid removed during ultrafiltration.
The magnitude of increment in COP during ultrafiltration is
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Fig. 4. Three groups (a, b, and c) of dialysis patients reported according
to amount offluid removed with ultrafiltration. Upper panel represents
absolute values of ultrafiltrate volume. Middle panel shows mean
percent change and standard error (% 5EM) from baseline value of
colloid osmotic pressure (COP). Lower panel represents the mean
change SEM of mean arterial pressure (MAP) values.
greater than that of the plasma protein concentration. This is
due to plasma COP being an exponential function of plasma
protein concentration [18]. This relationship was verified as
shown in Figure 2 and is consistent with previously published
work [181. This nonlinear increment in COP is explained in part
by COP in each specific solution being related not to the protein
concentration but to its chemical activity [231. From this
important physiologic concept, two points follow. First, any net
water loss from plasma causes a disproportionately large incre-
ment in COP, and second, the determination of COP may
reflect, more than any other parameter, changes in plasma
water concentration.
The progressive increase in COP, plasma protein concentra-
tion, and hematocrit observed in our patients during ultrafiltra-
tion is a manifestation of hemoconcentration with removal of
fluid. If the ultrafiltration rate exceeds the vascular refilling rate
from the interstitial space, a progressive depletion of plasma
volume will ensue [17]. A decrease in MAP follows intravascu-
lar volume contraction. The importance of hypovolemia in the
genesis of hypotension induced by ultrafiltration is well known
[3—51. In the present study, the magnitude of change in COP
observed at 60 mm of ultrafiltration is greater than that for MAP
(Fig. 3). Both changes reflect the effect of plasma water content
on COP and underlie the multifactorial nature of blood pressure
regulation.
Despite equivalent rates of ultrafiltration, the changes ob-
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Fig. 3. Mean change and standard error from the baseline value of the
mean arterial pressure (MAP) and colloid osmotic pressure (COP) in 18
dialysis patients, and the mean absolute value of ultrafiltrate volume
(UV) during 60 mm of ultrafiltration.
55000
550
4:
1
522 Rodriguez et a!
0 1
Fig. 5. Observed percent change in COP as exponentially related to
mean change in total protein (TP), hematocrit (Hct), and liters of
ultrafiltrate volume (UV). COP% = 2.397 + 1.36 TP% + 0.063 (
TP%)2, P <0.002; COP% = 3.051 + 0.47 Hct% + 0.102 ( Hct%)2, P
<0.0005; COP% = 1.359 + 1.841 UV + 3.329 (UV)2, P < 0.0001.
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observed among our patients are more pronounced than those
for either hematocrit or plasma protein concentration and the
error of determination for these parameters are comparable, it
is suggested that COP may be the more sensitive parameter of
changes in plasma volume. Recent experimental studies in the
dog subjected to various intravascular volume expansion ma-
neuvers have also shown that COP reflects better than any
other parameter shifts of fluid across capillary membranes [29].
Thus, direct measurements of COP reflecting net effective
changes in intravascular volume may become clinically useful
in monitoring the dialysis patient.
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served in COP at 15 mm are of greater magnitude than those
observed in the subsequent periods. A dominant net fluid loss
from the intravascular space during the early ultrafiltration
period may explain this observation. Later, as COP increases
and exceeds opposing Starling forces, recruitment of fluid
across the capillary wall from the interstitial space would
ameliorate the net intravascular loss of fluid. This interpretation
is in agreement with the refilling capacity rate hypothesis
advanced by Henderson [1].
As reported by others [12, 14], no significant changes in
plasma osmolarity were detected during ultrafiltration, presum-
ably because of isoosmotic fluid removal across the dialysis
membrane with this technique.
The close relationship between changes in COP and net loss
of fluid is clearly demonstrated in Figures 3 and 4. The larger
the amount of fluid removed, the more significant is the
increment in COP. The marked increase in COP observed in the
early stage of ultrafiltration, especially in group a, may reflect
substantial intravascular volume depletion, suggesting that a
lower ultrafiltration rate during the early period of treatment
may be more physiologic. No significant change in MAP during
ultrafiltration was observed in group c, indicating that the
removal of 1.5 liters within 1 hour is well tolerated and confirms
other observations [5, 141. As expected, COP was exponentially
related to total protein, hematocrit, and ultrafiltration volume
(Fig. 5). Thus, the relatively moderate changes in hematocrit
and total protein concentration contrast with the large changes
in COP. This exponential relationship also has been previously
noted with serial concentration of protein solutions or plasma
obtained from patients at single points in time [18, 20, 24—25].
To our knowledge, the current report, for the first time,
documents the exponential relationship of COP sequentially
during dynamic treatment in humans.
Recently, several reports have alluded to the validity of
utilizing hematocrit and total protein measurements to calculate
plasma volume changes [26—28]. Because the changes of COP
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